Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
07/2010
07/06/2010US7749485 Liposomal assembly for therapeutic and/or diagnostic use
07/06/2010US7749366 Isolation and cloning of DNA from uncultivated organisms
07/06/2010CA2522067C Detection, characterization and treatment of viral infection and methods thereof
07/06/2010CA2477433C Methods and materials for detecting genetic material
07/06/2010CA2461199C Atlastin
07/06/2010CA2436046C Method for efficiently producing transgenic plant using auxin precursor
07/06/2010CA2378408C Polynucleotide amplification method
07/06/2010CA2373491C Method of detecting interacting proteins
07/06/2010CA2366104C Ultra-fast transformation technique for monocotyledons
07/06/2010CA2363537C Cyclic gmp-binding, cyclic gmp-specific phosphodiesterase materials and methods
07/06/2010CA2328056C Attenuated mutants of salmonella which constitutively express the vi antigen
07/06/2010CA2286396C Oligonucleotides for enhanced bioavailability
07/06/2010CA2264509C Novel monoclonal antibody recognizing cell surface antigen cd14
07/06/2010CA2225547C Apparatus for the parallel alignment of macromolecules, and use thereof
07/06/2010CA2209360C Recombinant monoclonal anti-idiotype antibody 3h1 sequences relating to human carcinoembryonic antigen
07/06/2010CA2162729C Cloning and recombinant production of crf (corticotropin releasing factor) receptor(s)
07/06/2010CA2154945C Actinomadura xylanase sequences and methods of use
07/06/2010CA2123049C Pharmaceutical containing the p40 subunit of interleukin 12
07/01/2010WO2010075574A2 Enone reductases
07/01/2010WO2010075498A2 Axmi-150 delta-endotoxin gene and methods for its use
07/01/2010WO2010075476A2 Neural crest enhancers and methods for us
07/01/2010WO2010075441A1 Modular nucleic acid-based circuits for counters, binary operations, memory, and logic
07/01/2010WO2010075417A1 Survivin specific t cell receptor for treating cancer
07/01/2010WO2010075379A2 Electronic device including phenanthroline derivative
07/01/2010WO2010075375A1 Compositions, methods and related uses for cleaving modified dna
07/01/2010WO2010075360A2 Methods for detection of sepsis
07/01/2010WO2010075352A1 Pesticidal genes from brevibacillus and methods for their use
07/01/2010WO2010075303A1 Splicing factors with a puf protein rna-binding domain and a splicing effector domain and uses of same
07/01/2010WO2010075243A2 Nucleotide sequences encoding gsh1 polypeptides and methods of use
07/01/2010WO2010075213A2 Production of ethanol from lignocellulosic biomass
07/01/2010WO2010075194A1 Prokaryotic expression of soluble, active dkk
07/01/2010WO2010075188A2 Multibase delivery for long reads in sequencing by synthesis protocols
07/01/2010WO2010075143A1 Genes and uses for plant enhancement
07/01/2010WO2010075116A2 Nucleic acid purification apparatus and method
07/01/2010WO2010075101A2 Treating picornavirus infection by targeting microrna mir-141
07/01/2010WO2010075007A2 Determining nutrients for animals through gene expression
07/01/2010WO2010074999A1 Hybrid alpha-amylases
07/01/2010WO2010074859A2 Yeast-based methods of identifying nucleic acids and compounds for treating neurodegenerative diseases
07/01/2010WO2010074794A2 Membrane transduction peptides, polynucleotides, and methods
07/01/2010WO2010074562A1 Use of double stranded rna to increase the efficiency of targeted gene alteration in plant protoplasts
07/01/2010WO2010074266A1 Anti-cd4 antibody
07/01/2010WO2010074249A1 Nucleic acid derived from hepatitis c virus, and expression vector, transformed cell and hepatitis c virus particles each prepared by using same
07/01/2010WO2010074241A1 Method for predicting therapeutic effect of combination chemotherapy
07/01/2010WO2010074240A1 Method for predicting therapeutic effect of chemotherapy
07/01/2010WO2010074222A1 Method for producing lactic acid and method for producing polylactic acid
07/01/2010WO2010074218A1 Anti-human midkine antibody
07/01/2010WO2010074209A1 Mutant lipase and use thereof
07/01/2010WO2010074192A1 Diagnosis and treatment of cancer using anti-lgr7 antibody
07/01/2010WO2010074082A1 Modified vasohibin
07/01/2010WO2010074081A1 Protein substance having triple helix structure and manufacturing method therefor
07/01/2010WO2010074080A1 Expression vector for producing protein derived from foreign gene in large quantity using animal cells, and use thereof
07/01/2010WO2010074049A1 Anti-hs6st2 antibody and use thereof
07/01/2010WO2010073972A1 Method for obtaining pancreatic progenitor cell using neph3
07/01/2010WO2010073721A1 Prediction of effectiveness of preoperative chemoradiotherapy on rectal cancer using micro-rna
07/01/2010WO2010073697A1 Agent capable of doubling rice plant nuclear chromosome, and use thereof
07/01/2010WO2010073694A1 Diagnosis of treatment of cancer using anti-tm4sf20 antibody
07/01/2010WO2010073647A1 Human anti-human influenza virus antibody
07/01/2010WO2010073551A1 C1orf59 peptides and vaccines including the same
07/01/2010WO2010073544A1 Method for testing risk of coronary artery diseases
07/01/2010WO2010073247A2 Egfr-homing double-stranded rna vector for systemic cancer treatment
07/01/2010WO2010073104A2 Improving cognitive function
07/01/2010WO2010073043A1 Immunogenic composition and use thereof
07/01/2010WO2010073015A2 Peptide tag and uses thereof
07/01/2010WO2010072902A1 Conversion of hexuronic acid to hexaric acid
07/01/2010WO2010072900A1 Oncolytic adenoviral vectors and methods and uses related thereto
07/01/2010WO2010072834A1 Nucleic acid purification method
07/01/2010WO2010072821A1 Nucleic acid purification method
07/01/2010WO2010072804A1 Hnrnp a3 related peptides and use thereof for diagnosis of rheumatoid arthritis
07/01/2010WO2010072765A2 Mutant penicillin g acylases
07/01/2010WO2010072676A1 Mammalian expression vector
07/01/2010WO2010072600A1 Polyketide biosynthesis genes
07/01/2010WO2010072365A1 Single recombination system and methods of use
07/01/2010WO2010072210A1 Method for increasing the saccharose yield in agricultural production of sugar beets and sugar cane
07/01/2010WO2010072118A1 Probes, liquid phase chips and methods for detecting pik3ca gene mutations
07/01/2010WO2010071995A1 Tor-interacting proteins (tips) and genes therefor
07/01/2010WO2010071986A1 Modified steptococcus pneumonia pneumolysin (ply) polypeptides
07/01/2010WO2010071983A1 Mutated voltage-gated sodium channel nav alpha subunit for identification of modulators
07/01/2010WO2010071973A1 Modification of plant phenotypes through tor gene expression
07/01/2010WO2010071938A1 Novel collagen constructs
07/01/2010WO2010071915A1 Determinants of the acute sickness response
07/01/2010WO2010054348A3 Pathogen-inducible promoters and their use in enhancing the disease resistance of plants
07/01/2010WO2010053990A3 Crhr2 peptide agonists and uses thereof
07/01/2010WO2010046493A9 Gene transfer vectors comprising at least one isolated dna molecule having insulator and or boundary properties and methods to identify the same
07/01/2010WO2010045949A3 Apparatus and methods for analysing fluorescent particles
07/01/2010WO2010041021A3 Gene regulation using double stranded rna hairpin
07/01/2010WO2010040531A3 Process of clean cloning
07/01/2010WO2010040033A3 Methods and compositions for modulating an immune response with immunogenic oligonucleotides
07/01/2010WO2010039692A3 Transformed saccharomyces cerevisiae engineered for xylose utilization
07/01/2010WO2010039649A3 Flavivirus-based system for production of hepatitis c virus (hcv)
07/01/2010WO2010036986A3 Recombinant vectors
07/01/2010WO2010036970A3 Influenza vaccines, antigens, compositions, and methods
07/01/2010WO2010036795A3 Screening methods for identifying specific staphylococcus aureus inhibitors
07/01/2010WO2010036353A9 Genetic markers for optimizing treatment for schizophrenia
07/01/2010WO2010033825A3 Genetic variants associated with abdominal aortic aneurysms
07/01/2010WO2010033822A3 Therapeutic and diagnostic strategies
07/01/2010WO2010033818A3 Mirna targets
07/01/2010WO2010033580A3 Curcumin conjugates for treating and preventing cancers
07/01/2010WO2010031074A3 Compositions and methods for regulating cell osmolarity
07/01/2010WO2010030653A3 Nurr1 interacting protein (nuip)
07/01/2010WO2010027870A3 Assay methods for increased throughput of samples and/or targets
1 ... 988 989 990 991 992 993 994 995 996 997 998 999 1000 1001 1002 1003 1004 1005 1006 1007 1008 ... 4023